Facial Angiofibroma
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex (NCT03826628) | Dermatology Specialties Limited Partnership | 2019-07-28 |
| Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (NCT02654340) | CENTOGENE GmbH Rostock | 2018-08-01 |
| Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream (NCT01853423) | Le Bonheur Children's Hospital | 2013-10-01 |
| Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis (NCT03140449) | National Taiwan University Hospital | 2013-09-05 |
Track Facial Angiofibroma automatically
Every clearance here is in the API, with alerts when new ones post.